Insiders · HIHO

David E. Lazar

Chief Executive Officer, Director, 10% owner at Highway Holdings Ltd (HIHO) since November 2026

David E. Lazar has filed 48 insider reports with the SEC since July 2022, as chief Executive Officer, director and 10% owner at Highway Holdings Ltd (HIHO), chief Executive Officer and director at Aterian, Inc. (ATER) and chief Executive Officer, director and 10% owner at Quantum Cyber N.V. (QUCY) and at 10 more companies. David E. Lazar made no open-market purchases or sales in the last 12 months. The latest filing, on November 9, 2026, is a Form 3: David E. Lazar became an insider at Highway Holdings Ltd (HIHO).

Schedule 13D and 13G filings by David E. Lazar

Filings
48
Companies
13
Bought on market
$2.03M
Sold on market
$14.8M

Companies where David E. Lazar is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Highway Holdings Ltd logo
HIHO
Highway Holdings Ltd
Chief Executive Officer, Director, 10% ownersince November 20260$1.43Nov 9, 2026
Aterian, Inc. logo
ATER
Aterian, Inc.
Chief Executive Officer, Directorsince April 20268,038,030$1.04Sep 30, 2026
Quantum Cyber N.V. logo
QUCY
Quantum Cyber N.V.
Chief Executive Officer, Director, 10% ownersince February 202655,057,500$0.512Aug 7, 2026
Sow Good Inc. logo
SOWG
Sow Good Inc.
Chief Executive Officer, Directorsince December 20255,740,000$2.37Apr 2, 2026
Indaptus Therapeutics, Inc. logo
INDP
Indaptus Therapeutics, Inc.
Co-Chief Executive Officer, Directorsince December 20250$2.82Mar 24, 2026
NovaBay Pharmaceuticals, Inc. logo
SDEV
NovaBay Pharmaceuticals, Inc.
Chief Executive Officer, 10% ownersince August 20256,388,000$0.50Jan 30, 2026
KALA BIO, Inc. logo
KALA
KALA BIO, Inc.
Chief Executive Officer, Directorsince November 20250$2.705Dec 22, 2025
Cyclacel Pharmaceuticals, Inc. logo
BGMS
Cyclacel Pharmaceuticals, Inc.
Interim CEO, 10% ownersince January 2025155,838$5.59M$0.553Aug 4, 2025
LQR House Inc. logo
YHC
LQR House Inc.
President, Directorsince October 2024100,000$1.59Apr 7, 2025
FiEE, Inc. logo
FIEE
FiEE, Inc.
Director, 10% ownersince December 20232,681,980$50K$0.03$2.72+8967%Mar 10, 2025
Opgen Inc logo
OPGN
Opgen Inc
Chief Executive Officer, Director, 10% ownersince March 2024100,000Aug 1, 2024
Tracon Pharmaceuticals, Inc. logo
TCON
Tracon Pharmaceuticals, Inc.
Chief Business Dev Officersince May 2024May 13, 2024
Titan Pharmaceuticals Inc logo
TTNP
Titan Pharmaceuticals Inc
Officer, Directorsince July 2022100,000$1.98M$9.22M$0.87Jul 31, 2023

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Also sits on boards with

Officers and directors who share two or more companies with David E. Lazar.

Compare David E. Lazar with

Other insiders at the same companies

Questions about David E. Lazar

What is David E. Lazar's role at Highway Holdings Ltd?
David E. Lazar reports to the SEC as chief Executive Officer, director and 10% owner at Highway Holdings Ltd (HIHO), according to the latest filing on November 9, 2026. David E. Lazar has also filed as chief Executive Officer and director at Aterian, Inc. (ATER), chief Executive Officer, director and 10% owner at Quantum Cyber N.V. (QUCY), chief Executive Officer and director at Sow Good Inc. (SOWG) and co-Chief Executive Officer and director at Indaptus Therapeutics, Inc. (INDP).
How many shares does David E. Lazar own?
After the latest filing that states it, David E. Lazar directly owned 8,038,030 shares of Aterian, Inc. (ATER), 55,057,500 shares of Quantum Cyber N.V. (QUCY), 5,740,000 shares of Sow Good Inc. (SOWG), 6,388,000 shares of NovaBay Pharmaceuticals, Inc. (SDEV) and 155,838 shares of Cyclacel Pharmaceuticals, Inc. (BGMS). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has David E. Lazar bought or sold stock recently?
The most recent open-market purchase was on December 26, 2024: bought 1,456,980 shares of Minim, Inc. (FIEE) for $50K at an average of $0.03. The most recent open-market sale was on July 30, 2025: sold 6,750 shares of Cyclacel Pharmaceuticals, Inc. (BGMS) for $83.4K at an average of $12.36.
How do I get alerts when David E. Lazar files?
Follow David E. Lazar on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. David E. Lazar filed 3 times in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by David E. Lazar (SEC CIK 0001932843). Totals count each trade once, skipping amendments whose original is on file, from Jul 8, 2022 on. View on SEC EDGAR · Get this as JSON